# OnCo record mrd-testing (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/mrd-testing/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "mrd-testing" ;
  schema:name "MRD / molecular residual disease testing"@en ;
  schema:description "An ultra-sensitive blood test after surgery that detects leftover cancer months before a scan would."@en ;
  schema:url <https://onco.cc/technologies/mrd-testing/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Minimal_residual_disease> ;
  owl:sameAs <http://www.wikidata.org/entity/Q6865356> ;
  schema:citation <https://en.wikipedia.org/wiki/Minimal_residual_disease> ;
  onco:status "established" ;
  onco:related <https://onco.cc/roadmaps/ctdna-tests/>, <https://onco.cc/ideas/idea-dtc-colonisation-determinants/>, <https://onco.cc/ideas/idea-dormancy-maintenance-therapy/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:companies <https://onco.cc/companies/natera/>, <https://onco.cc/companies/exact-sciences/>, <https://onco.cc/companies/guardant-health/>, <https://onco.cc/companies/adela/>, <https://onco.cc/companies/billiontoone/>, <https://onco.cc/companies/c2i-genomics/>, <https://onco.cc/companies/haystack-oncology/>, <https://onco.cc/companies/inivata/>, <https://onco.cc/companies/isabl/>, <https://onco.cc/companies/mission-bio/>, <https://onco.cc/companies/naveris/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/> ;
  onco:trials <https://onco.cc/trials/imvigor011/>, <https://onco.cc/trials/dynamic/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-tie-ctdna-minimal-residual-disease-stage-ii-colon-sci-transl-med-2016/>, <https://onco.cc/key-papers/paper-reinert-ctdna-ultradeep-sequencing-colorectal-jama-oncol-2019/>, <https://onco.cc/key-papers/paper-henriksen-ctdna-stage-iii-colorectal-improve-it-ccr-2022/>, <https://onco.cc/key-papers/paper-dynamic-nejm-2022/>, <https://onco.cc/key-papers/paper-galaxy-signatera-nat-med-2023/> ;
  onco:dependsOn <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/ngs-bioinformatics-software/> .